From: Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer
Characteristic | No. of patients (% of total) |
---|---|
Medically inoperable | 33 (85) |
Refused surgery | 6 (15) |
Charlson Comorbidity Score | |
0-2 | 20 (51) |
03-apr | 13 (33) |
<3 | 6 (15) |
Median Cumulative Illness Ranking (range) | 6 (2–16) |
Incidence of COPD | 22 (56) |
Tumor location | |
Peripheral | 33 (85) |
Central | 6 (15) |
T-classification | |
T1 | 17 (44) |
T2 | 21 (54) |
T3 | 1 (3) |
Histology | |
Squamous cell carcinoma | 14 (36) |
Large cell carcinoma | 13 (33) |
Adenocarcinoma | 8 (21) |
Other | 4 (10) |
PTV median (cc) (range) | 46 (7–609) |